FEDERAL COURT OF AUSTRALIA
H. Lundbeck A/S v Sandoz Pty Ltd [2018] FCA 1797
File numbers:
NSD 647 of 2014
NSD 824 of 2016
Judge:
JAGOT J
Date of judgment:
21 November 2018
Catchwords:
PATENTS – construction of claims – (+) and (−)-enantiomers – where patent claims separated (+)-enantiomer – no defence to infringement where only trace, trivial or insignificant amounts of (−)-enantiomer present in infringing products – claims of patent infringed
PATENTS – whether patentee/exclusive licensee prevented from brining infringement proceedings under provisions of the Patents Act 1990 (Cth)
CONTRACTS – construction of settlement agreement – licence to exploit the invention the subject of the patent in suit – licence no defence to infringement
DAMAGES – innocent infringement – discretionary defences – whether award of additional damages appropriate – assessment of damages for patent infringement – object of award of damages to restore patentee and/or exclusive licensee to the position each would have been in but for infringement
Legislation:
Acts Interpretation Act 1901 (Cth), s 12
Australian Consumer Law, s 18
Competition and Consumer Act 2010 (Cth)
Copyright Act 1968 (Cth), s115(4)
Designs Act 2003 (Cth), s 75(3)
Federal Court of Australia Act 1976 (Cth), s 51A
Patents Act 1952 (Cth)
Patents Act1990 (Cth), ss 3, 13, 15AB, 18, 32, 36, 40, 41, 42, 54, 55, 65, 67, 70, 71, 72, 75, 76, 77, 78, 79, 79C, 83, 85, 101E, 101F, 120, 122, 123, 133, 136H, 136J, 142, 143, 143A, 145, 147, 148, 149, 150, 151, 165A, 215, 223, 227 and 228
Trade Marks Act 1995 (Cth), s 126
Trade Practices Act 1974 (Cth)
Federal Court Rules 2011 (Cth), r 39.06
Patents Regulations 1991 (Cth), reg 22.21
Explanatory Memorandum, Patents Bill 1990 (Cth), cl 77
Cases cited:
Actavis Pty Ltd v Orion Corporation [2016] FCAFC 121
Advanced Building Systems Pty Ltd v Ramset Fasteners (Aust) Pty Ltd [1995] FCA 236; (1995) AIPC 91-129
Advanced Building Systems Pty Ltd v Ramset Fasteners (Aust) Pty Ltd [2001] FCA 1098; (2001) 52 IPR 305
Alphapharm Pty Ltd vH Lundbeck A/S [2006] APO 18; (2006) 69 IPR 629
Alphapharm Pty Ltd v H Lundbeck A/S [2008] FCA 559; (2008) 76 IPR 618
Alphapharm Pty Ltd v H Lundbeck A/S [2011] APO 36; (2011) 92 IPR 628
Alphapharm Pty Ltd v H Lundbeck A/S [2014] APO 41; (2014) 109 IPR 323
Alphapharm Pty Ltd v H Lundbeck A/S [2014] HCA 42; (2014) 254 CLR 247
Alphapharm Pty Ltd v H Lundbeck A/S [2015] FCAFC 138; (2015) 234 FCR 306
Alphapharm Pty Ltd v H Lundbeck A/S [2014] FCA 1185; (2014) 110 IPR 59
Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd(No 2) [2012] FCAFC 102; (2012) 204 FCR 494
Aristocrat Technologies Australia Pty Limited v DAP Services (Kempsey) Pty Limited (in liquidation) [2007] FCAFC 40; (2007) 157 FCR 564
Aspen Pharma Pty Ltd v Commissioner of Patents [2012] AATA 851; (2012) 132 ALD 648
Keep reading for free
Create a free CaseChat account to read H Lundbeck A/S v Sandoz Pty Ltd and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2018] FCA 1797
- Decision Date
CaseChat Overview and Summary
The primary legal issues in the case were the construction of the patent claims and whether Sandoz's products infringed those claims. The court had to determine if the presence of trace, trivial, or insignificant amounts of a different enantiomer in Sandoz's products constituted an infringement. Another issue was whether the settlement agreement between Lundbeck and Sandoz provided a defense to the infringement claims. The court also considered whether additional damages were appropriate for innocent infringement and how to assess the damages for the patent infringement.
The court found that Sandoz's products did indeed infringe the claims of the 144 patent as the presence of trace amounts of a different enantiomer did not negate the infringement. The settlement agreement did not provide a defense to the infringement claims as it was a license to exploit the invention, not a defense to infringement. The court also determined that the award of additional damages for innocent infringement was not appropriate as the object of the award was to restore the patentee to the position they would have been in but for the infringement. The damages were to be calculated in a manner generally consistent with the approach of the accountant called by the applicants, subject to a discount of 30% to account for the risks associated with the past hypothetical cash-flows.
The final orders of the court included provisions for the confidentiality of the reasons for judgment, the provision of the reasons to the Patent Office, and the extension of time for filing a notice of appeal. The parties were also directed to propose further directions to finalize the litigation, including orders to enable the expert accounting witnesses to confer and provide a further joint report if necessary.
Orders
Orders of the court
1. Subject to order 2, until 5.00pm on 28 November 2018, pursuant to s 37AF of the Federal Court of Australia Act 1976 (Cth) and on the ground that it is necessary to prevent prejudice to the proper administration of justice under s 37AG(1)(a), there be no disclosure (by publication or otherwise) of the reasons for judgment delivered on the date of this order in proceedings NSD 647 of 2014 and NSD 826 of 2016 (Proceedings) to any person other than to the external solicitors, expert accounting witnesses, and counsel for the parties in the Proceedings and Lundbeck In-house Counsel and Sandoz In-house Counsel (as defined in the Confidentiality Agreement dated 30 May 2017).
2. The reasons for judgment may be provided to the Patent Office in relation to the Application for Licence to Exploit an Invention made by the Respondent to the Patent Office on 18 December 2013, provided that the Commissioner of Patents makes a direction under regulation 4.3(2)(a) and / or 4.3(2)(b) that the reasons for judgment will not be open to public inspection pending the making of any confidentiality orders referred to in order 6.
3. By 4.00pm on 28 November 2018 any party wishing to claim that any part of the reasons for the judgment should be subject to a further confidentiality order is to notify the Associate to Jagot J and the other parties, by email of the claim including:
(a) details of the matter claimed to be confidential;
(b) a short statement of the reasons the matter is said to be confidential; and
(c) a statement identifying whether the claimant consents to the confidentiality claim being determined by Jagot J on the basis of the email or seeks an oral hearing.
4. If no notice by email is received in accordance with order 3, the reasons for judgment will be published forthwith.
5. If notice is received in accordance with order 3, the reasons for judgment will be published forthwith with the claimed confidential matter redacted pending determination of the confidentiality claim.
6. The parties are to confer and, by 4.00pm on 5 December 2018, are to propose in a joint email (including agreed and disagreed matters) to the Associate to Jagot J further directions to enable the matter to be finalised, including orders to enable the expert accounting witnesses to confer and provide a further joint report, if necessary, in respect of any outstanding issues having regard to the reasons for judgment.
7. Pursuant to rule 36.03(b) of the Federal Court Rules 2011 (Cth), the time within which a party may file and serve any notice of appeal from judgment in these proceedings be extended to and for a period of 21 days after the publication of the reasons for judgment pursuant to orders 4 or 5, or the date of the determination of any outstanding issues raised by the expert accounting witnesses in any further joint report pursuant to order 6, whichever is later.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
Background
Background to the litigation
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.